| |
| | The pharmaceutical industry has been lagging behind other industries when it comes to digitization, but incumbents are now signaling their interest in digital health—and one of the most disruptive technology incumbents are tapping is AI to slash the time and resources needed to bring a drug to market.
In The AI in Drug Discovery and Development Report, Insider Intelligence outlines the various stages within the drug discovery and development process—noting where AI can be leveraged in to reduce costs and shrink time frames. We provide examples of startups working to employ AI at various stages, and explain how tech giants are making use of their AI brawn to forge alliances with pharma companies. Finally, we highlight the barriers that remain hindering AI's use in drug discovery and development. | In full, this exclusive report: | | |
| 1 | Outlines the ways in which AI can be leveraged to streamline the multiple phases of drug development | | 2 | Identifies AI's cost- and time-saving potential for drug discovery and development | | 3 | Gives a snapshot of how startups and big tech companies are working with drugmakers to deploy AI for drug R&D | | 4 | Discusses barriers that are still hindering AI's implementation in the space |
Get all of these insights and more when you purchase the AI in Drug Discovery and Development Report for $995. | | |
| |
| |
| |
0 comments:
Post a Comment